期刊文献+

Survivin和NF-κB在胃癌中的表达及其相关性 被引量:3

Correlation between the expression of survivin and NF-κB in gastric cancer
暂未订购
导出
摘要 目的探讨胃癌组织中Survivin和NF-κB在胃癌中的表达及其相关性,并初步探讨Survivin和NF-κB相互作用机制。方法采用免疫组织化学技术S-P法检测60例胃癌组织及相应的癌旁组织及30例胃正常组织中Survivin和NF-κB的表达情况。结果Survivin和NF-κB在胃癌中的表达呈正相关(r=0.443,P<0.05),阳性表达率明显高于癌旁组织及胃正常组织(P<0.05);而癌旁组织阳性表达率高于胃正常组织(P<0.05)。结论survivin及NF-κB在胃癌组织中特异性高表达,在癌旁组织、胃正常组织中的弱表达或不表达,提示它们可能参与了胃癌的发生与发展。 Objective To investigate the expression of survivin, NF-κB and their clinical significance in gastric cancer. Methods Steptative-peroxidase-biotin immunohistochemistry technique was used to detect the expression of survivin and NF-κB in sixty gastric carcinoma specimens, sixty gatric mucosa membrane adjacent tumor specimens and thirty normal gastric mucosa membrane specimens. Results There was a positive correlation between the positive expression of survivin and NF-κB in sixty gastric carcinoma specimens( r = 0.443, P〈 0.05). The positive expression rate of survivin and NF-κB in gastric carcinoma was significantly higher than in mucosa membrane adjacent tumor and in normal gastric mucosa membrane( P 〈 0.05, P 〈 0.05 ) ; The positive expression rate of survivin and NF-κB in mucosa membrane adjacent tumor was higher than in normal gastric mucosa membrane(P〈0.05) .Conclusion The expression of survivin and NF-κB in gastric carcinoma tissues is much higher than that in mucosa membrane adjacent tumor and in normal gastric muctric membrane which is weaker or no neuropilin-1 expression; It suggests that they may play an important role in gastric tumorigenesis and development.
出处 《广西医学》 CAS 2006年第10期1512-1515,共4页 Guangxi Medical Journal
关键词 胃癌 SURVIVIN NF—κB 凋亡 免疫组化 Gastric carcinoma Survivin NF-κB Apoptosis Immunohistochemistry
  • 相关文献

参考文献16

  • 1Reed JC.Dysregulation of apoptosis in cancer[J].J Clin Oncol,1999,17(9):2 941~2 953.
  • 2Tamm l,Wang Y,Sausville E,et al.lAP-family protein Survivin inhibits caspase activity and apoptosis induced by Fas(CD95),Bax,caspase,and anticancer drugs[J].Cnacer Res,1998,58(23):5 315~5317.
  • 3Li F.Altieri DC.The cancer antiapoptosis mouse surviving gene:characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression[J].Cancer Res,1999,59(3):3 143~3 151.
  • 4Tran J,Master Z,Yu JL,et al.A role for survivin in chemoresistance of I endothelial cells mediated by VEGF[J].Proc Nati Acad Sci USA,2002,99(7):4 349~4 354.
  • 5Kawasaki H,Altieri DC,Lu CD,et al.Inhibition of apoptosis by Survivin predicts shorter survival rates in colorectal cancer[J].Cancer Res,1998,58(22):5 071~5 074.
  • 6Sarela AI,Scott N,Ramsdale J,et al.Immunohistochemical detection of the amtrapoptosis protein,Survivin,predicts survival after curative resection of stage II colorectal carcinomas[J].Ann Surg Oncol,2001,8(5):305~310.
  • 7Okada E,Murai Y,Matsui K,et al.Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients[J].Cancer Lett,2001,163(1):109~116.
  • 8Wakana Y,kasuya K,Katayanagi S,el al.Effect of survivin on cell proliferation and apoptosis in gastric cancer[J].Oncol Rep,2002,9(6):1 213~1 218.
  • 9Yu T,Leung WK,Eben MP.et al.Increased expression of Survivin in gastric cancer patients and in first degree relatives[J].Br I Cancer,2002,87(1):91~92.
  • 10Papapetropoulos A,Fulton D,Mahboubi K,et al.Angioetin-I inhibits endothelial cell[J].J Bid Chem,2000,275(13):9 102~9 105.

二级参考文献1

  • 1张佩范 张荫昌.胃癌.胃癌病理及胃粘膜活检[M].沈阳:辽宁科学技术出版社,1988.75-98.

共引文献29

同被引文献35

  • 1潘立峰,李巧霞,单保恩,王俊霞.VEGF反义RNA对人食管癌细胞抑制作用的研究[J].中国肿瘤生物治疗杂志,2005,12(1):41-45. 被引量:5
  • 2吴焕文,杨桂芳,罗峻,龚玲玲,熊永炎.人胃腺癌中NF-κBp65、VEGF、Survivin的表达及意义[J].中华消化内镜杂志,2006,23(6):436-439. 被引量:4
  • 3Sarkar FH,Li Y,Wang Z,et al.NF-kappaB signaling pathway and its therapeutic implications in human diseases[J].Int Rev Immunol,2008,27(5):293-319.
  • 4Mosialos G.The role of Rel/ NF-κB protein in viral oncogenesis and the regulation of viral transformation[J].Semin Cancer Biol,1997,8(11):121-129.
  • 5Chan CF,Yau TO,Jin DY,et al.Evaluation of nuclear factor-kappaB,urokinase-type plasminogen activator,and HBx and their clinicopathological significance in hepatocellular carcinoma[J].Clin Cancer Res,2004,10(12):4140-4149.
  • 6Ferrara N,Kerbel RS.Angiogenesis as a therapeutic target[J].Nature,2005,438(7070):967-974.
  • 7Keating GM,Santoro A.Sorafenib:a review of its use in advanced hepatocellular carcinoma[J].Drugs,2009,69(2):223-240.
  • 8Elsharkawy AM,Mann DA.Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis[J].Hepatology,2007,46(2):590-597.
  • 9Karin M.Nuclear factor-kappaB in cancer development and progression[J].Nature,2006,441(7092):431-436.
  • 10孙平,王莹,刘跃光.VEGF-C在食管癌淋巴转移中的作用及临床意义[J].牡丹江医学院学报,2007,28(4):4-6. 被引量:5

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部